Drug delivery system targeting advanced hepatocellular carcinoma: Current and future
Hepatocellular carcinoma (HCC) has a fairly high morbidity and is notoriously difficult to treat
due to long latent period before detection, multidrug resistance and severe drug-related …
due to long latent period before detection, multidrug resistance and severe drug-related …
Nanotechnology based approach for hepatocellular carcinoma targeting
Hepatocellular carcinoma (HCC) is the primary liver cancer that has shown a high incidence
and mortality rate worldwide among several types of cancers. A large variety of …
and mortality rate worldwide among several types of cancers. A large variety of …
Nanocarrier-based tumor-targeting drug delivery systems for hepatocellular carcinoma treatments: Enhanced therapeutic efficacy and reduced drug toxicity
T Tian, J Ruan, J Zhang, CX Zhao… - Journal of biomedical …, 2022 - ingentaconnect.com
Hepatocellular carcinoma (HCC), due to the lack of efficient diagnostic methods and short of
available treatments, becomes the third main cause of cancer deaths. Novel treatments for …
available treatments, becomes the third main cause of cancer deaths. Novel treatments for …
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
M Li, W Zhang, B Wang, Y Gao, Z Song… - International Journal of …, 2016 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …
Drug delivery strategy in hepatocellular carcinoma therapy
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide,
with high rates of recurrence and death. Surgical resection and ablation therapy have limited …
with high rates of recurrence and death. Surgical resection and ablation therapy have limited …
[HTML][HTML] Nanoparticle drug delivery systems in hepatocellular carcinoma: a focus on targeting strategies and therapeutic applications
Hepatocellular carcinoma (HCC) is recognized as a global health issue accounting for
millions of deaths every year. Surgery, liver ablation, and embolization therapy are amongst …
millions of deaths every year. Surgery, liver ablation, and embolization therapy are amongst …
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma
C Turato, A Balasso, V Carloni, C Tiribelli… - Journal of Controlled …, 2017 - Elsevier
Hepatocellular carcinoma, the most frequent solid tumor of the liver, has a very poor
prognosis, being the second most common cause of death from cancer worldwide. The …
prognosis, being the second most common cause of death from cancer worldwide. The …
Recent progress of nano-drug delivery system for liver cancer treatment
F Zhou, F Teng, P Deng, N Meng… - Anti-Cancer Agents in …, 2017 - ingentaconnect.com
Liver cancer is one of serious diseases which threaten human life and health. Studies on the
treatment of liver cancer have attracted widespread attention. Application of nano-drug …
treatment of liver cancer have attracted widespread attention. Application of nano-drug …
Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma
MH Elnaggar, AI Abushouk, AHE Hassan… - Seminars in cancer …, 2021 - Elsevier
The effectiveness of chemotherapy in hepatocellular carcinoma (HCC) is restricted by
chemo-resistance and systemic side effects. To improve the efficacy and safety of …
chemo-resistance and systemic side effects. To improve the efficacy and safety of …
Nanomedicine in management of hepatocellular carcinoma: challenges and opportunities
Hepatocellular carcinoma is the second leading cause of cancer deaths worldwide. It is
characterized by unique features that can be utilized for selective and targeted therapy …
characterized by unique features that can be utilized for selective and targeted therapy …